Physician

William George Espar, M.D.

According to 2025 Medicare claims, William Espar, M.D. (NPI: 1952396855) practices cardiology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is FRANCISCAN PHYSICIAN NETWORK (NPI: 1225327984; TIN: 611630276) and primary practice location at 46360-4358. Espar is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Espar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,723 traditional Medicare patients, billed 3,922 HCPCS/CPT codes, and received $133,776 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 5,430 prescription claims across 776 beneficiaries totaling $817,949 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 13 claims. Open Payments data shows 105 records totaling $4,565. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $357,422 to $133,776. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $324,237 to $817,949. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $7,436 and ending at $14,762.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,994	6,752	$357,422
2016	2,841	8,299	$333,588
2017	2,142	6,111	$208,698
2018	2,145	5,688	$189,125
2019	2,095	5,782	$213,532
2020	1,701	4,252	$158,658
2021	1,789	4,316	$158,056
2022	1,810	4,248	$149,219
2023	1,593	3,708	$134,109
2024	1,723	3,922	$133,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	478	4,721	$324,237
2016	546	5,048	$366,868
2017	598	5,672	$471,835
2018	654	6,341	$606,071
2019	650	5,977	$673,269
2020	636	5,117	$633,978
2021	644	4,698	$605,127
2022	729	5,107	$713,241
2023	777	5,290	$863,600
2024	776	5,430	$817,949

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$137
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$21,596
2020	N/R	151	$9,776
2021	N/R	45	$2,252
2022	N/R	13	$228
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	420	463	$53
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	318	321	$47
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	146	148	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	471	489	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	655	997	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	234	15,855	$303,435
Xarelto	Rivaroxaban	185	9,693	$179,775
Entresto	Sacubitril/Valsartan	75	4,020	$89,568
Repatha Sureclick	Evolocumab	49	2,840	$56,501
Brilinta	Ticagrelor	58	2,673	$39,107

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$4,565	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William George Espar, M.D.?

Tedicare shows public-source Medicare data for William George Espar, M.D. (NPI 1952396855), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William George Espar, M.D. have ACO affiliation data?

William George Espar, M.D. is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to William George Espar, M.D.?

William George Espar, M.D. is linked to FRANCISCAN PHYSICIAN NETWORK (billing NPI 1225327984) in the available physician profile data.

Does William George Espar, M.D. have Open Payments data?

William George Espar, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.